BCIQ Profiles

Company Profile Report

Accelerating the fight against COVID-19 with real-world data on tests

Diagnostic Evidence Accelerator deploying real-world data against COVID-19

Almost every aspect of the fight against COVID-19 depends on the ability to determine whether an individual is or has been infected with SARS-CoV-2, but more than six months into the pandemic there is still uncertainty about the accuracy of widely used PCR-based diagnostics and serological antibody tests. The Reagan-Udall Foundation for the FDA and Friends of Cancer Research have launched an initiative, the COVID-19 Diagnostics Evidence Accelerator, that is intended to reduce that uncertainty by collecting and analyzing real-world data about test performance.

Knowledge about how tests actually

Read the full 898 word article

How to gain access

Continue reading with a
two-week free trial.